These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 25355310

  • 21. AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial.
    Lipton RB, McGinley JS, Shulman KJ, Silberstein SD, Wirth RJ, Buse DC.
    Headache; 2018 Feb; 58(2):229-242. PubMed ID: 29034453
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study.
    Carpay J, Schoenen J, Ahmad F, Kinrade F, Boswell D.
    Clin Ther; 2004 Feb; 26(2):214-23. PubMed ID: 15038944
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
    Asadollahi S, Heidari K, Vafaee R, Forouzanfar MM, Amini A, Shahrami A.
    Headache; 2014 Jan; 54(1):94-108. PubMed ID: 24182419
    [Abstract] [Full Text] [Related]

  • 26. Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.
    Law S, Derry S, Moore RA.
    Cochrane Database Syst Rev; 2016 Apr 20; 4(4):CD008541. PubMed ID: 27096438
    [Abstract] [Full Text] [Related]

  • 27. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R, Elkind A, Baker CC, Mullican W, DeBussey S, Asgharnejad M.
    Neurology; 1997 Nov 20; 49(5):1225-30. PubMed ID: 9371898
    [Abstract] [Full Text] [Related]

  • 28. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 Nov 20; 17(9):653-67. PubMed ID: 12828501
    [Abstract] [Full Text] [Related]

  • 29. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan 20; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L.
    CNS Drugs; 2005 Jan 20; 19(2):125-36. PubMed ID: 15697326
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J, Cady R, Singer R, Peters K, Webster C, Kori S, Byrd S.
    Clin Ther; 2006 Apr 20; 28(4):517-26. PubMed ID: 16750463
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.